PACLITAXEL PLUS OR MINUS EPIRUBICIN AS SALVAGE TREATMENT IN METASTATIC BREAST-CANCER PATIENTS (PTS) RELAPSED AFTER HIGH-DOSE CHEMOTHERAPY (HDC) PLUS PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) TRANSPLANTATION

Citation
G. Lelli et al., PACLITAXEL PLUS OR MINUS EPIRUBICIN AS SALVAGE TREATMENT IN METASTATIC BREAST-CANCER PATIENTS (PTS) RELAPSED AFTER HIGH-DOSE CHEMOTHERAPY (HDC) PLUS PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 193-193
Citations number
NO
Categorie Soggetti
Hematology,Oncology,Immunology,Transplantation
Journal title
ISSN journal
02683369
Volume
21
Year of publication
1998
Supplement
1
Pages
193 - 193
Database
ISI
SICI code
0268-3369(1998)21:<193:PPOMEA>2.0.ZU;2-8